Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history. (2022)

First Author: Lavezzo E
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13073-022-01066-2

PubMed Identifier: 35689243

Publication URI: http://europepmc.org/abstract/MED/35689243

Type: Journal Article/Review

Volume: 14

Parent Publication: Genome medicine

Issue: 1

ISSN: 1756-994X